Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
/Qualifications research, organisation, engineering Additional Information Website for additional job details https://www.ucd.ie/ Work Location(s) Number of offers available1Company/InstituteUniversity College
-
19 Dec 2025 Job Information Organisation/Company Radboud University Medical Center (Radboudumc) Research Field Engineering » Biomedical engineering Engineering » Electrical engineering Medical
-
applied to improving disease resistance. This postdoc project is part of the Gravitation program, GreenTE (Green Tissue Engineering), a multidisciplinary consortium of 7 Dutch universities. Together
-
position is available immediately in the Laboratory for Stem Cells and Tissue Engineering directed by Dr. Gordana Vunjak-Novakovic. We are looking for a highly motivated Research Scientist to join our team
-
biotechnology, bioprocess engineering, biomedical sciences, tissue engineering, cell biology, or a relevant field in biosciences. Significant hands-on experience with animal cell culture techniques, including
-
for complications. The CSFA serves as the first assistant in designated surgical procedures under the direct supervision of the operating surgeon/physician; handles all variety of tissue appropriately to reduce the
-
in all aspects of Histopathology to include tissue processing, sectioning of frozen and EM blocks, and tissue staining. Responsibilities 70% - Tissue preparation for subsequent EM studies: embedding
-
Details Title Postdoctoral Fellow – Cellular Microenvironments / Vascularized Tissue Development. School Wyss Institute for Biologically Inspired Engineering Department/Area Position Description
-
DWI-Leibniz-Institute für Interaktive Materialien e.V. | Aachen, Nordrhein Westfalen | Germany | about 1 month ago
to develop further both professionally and personally in an interdisciplinary setting. Position The DWI is looking for a Postdoctoral researcher to develop new granular biomaterials for tissue engineering
-
engineer (IR) for a 12-month period, aims to develop a new generation of anticancer drugs called degraders (PROteolysis TArgeting Chimeras, PROTACs). These innovative molecules do not simply block a target